Marijana Matas, Department of Anesthesiology, Reanimatology and Intensive Care Medicine, University Hospital Center Zagreb, Kišpatićeva 12, 10000 Zagreb, Croatia,
Croat Med J. 2021 Aug 31;62(4):338-346. doi: 10.3325/cmj.2021.62.338.
To compare the effect of adjunctive lidocaine-based scalp block and laryngotracheal local anesthesia vs general anesthesia only on pro-inflammatory cytokine concentrations in patients with non-ruptured brain aneurysms undergoing elective open surgery.
This parallel, randomized, controlled, open-label trial was conducted at Clinical Hospital Center Zagreb between March 2019 and March 2020. At the beginning of anesthesia, lidocaine group received 40 mg of 2% lidocaine for laryngotracheal topical anesthesia and 4 mg/kg for the scalp block. Control group underwent general anesthesia only. Plasma concentrations of IL-6, TNF-α, and IL-1β were measured before anesthesia (S0); at the incision (S1); at the end of surgery (S2); 24 hours postoperatively (S3). Cerebrospinal fluid (CSF) cytokine concentrations were measured at the incision (L1) and the end of surgery (L2).
Forty patients (each group, 20) were randomized; 37 were left in the final analysis. IL-6 plasma concentrations increased significantly compared with baseline at S3 in lidocaine group, and at S2 and S3 in control group. In both groups, changes in TNF-α and IL-1β were not significant. CSF cytokine concentrations in lidocaine group did not change significantly; in control group IL-6 and IL-1β were significantly higher at L2 than at L1. CSF IL-6 in control group significantly increased at L2, but TNF-α and IL-1β did not. No differences in clinical outcome and complication rates were observed.
Adjunctive lidocaine-based scalp block and laryngotracheal local anesthesia might attenuate CSF IL-6 concentration increase in patients with brain aneurysm.
比较辅助利多卡因头皮阻滞和喉气管局部麻醉与单纯全身麻醉对择期开颅手术非破裂脑动脉瘤患者促炎细胞因子浓度的影响。
这是一项在 2019 年 3 月至 2020 年 3 月期间在萨格勒布临床中心医院进行的平行、随机、对照、开放性临床试验。在麻醉开始时,利多卡因组接受 40mg 2%利多卡因进行喉气管局部麻醉和 4mg/kg 进行头皮阻滞。对照组仅接受全身麻醉。在麻醉前(S0);切口时(S1);手术结束时(S2);术后 24 小时(S3)测量血浆中 IL-6、TNF-α 和 IL-1β 的浓度。在切口时(L1)和手术结束时(L2)测量脑脊液(CSF)细胞因子浓度。
40 名患者(每组 20 名)被随机分组;最终有 37 名患者进入了最终分析。与基线相比,利多卡因组 S3 时 IL-6 血浆浓度显著升高,对照组 S2 和 S3 时也显著升高。两组 TNF-α 和 IL-1β 的变化均不显著。利多卡因组 CSF 细胞因子浓度无明显变化;对照组 L2 时 IL-6 和 IL-1β 明显高于 L1。对照组 CSF IL-6 在 L2 时显著升高,但 TNF-α 和 IL-1β 没有升高。未观察到临床结果和并发症发生率的差异。
辅助利多卡因头皮阻滞和喉气管局部麻醉可能减轻脑动脉瘤患者 CSF IL-6 浓度的升高。